ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1089

Commensal Gut Bacteria of Anti-Ro Positive Mothers of Children with Neonatal Lupus in Aggregate Resemble Healthy Subjects without Overt Dysbiosis of Abundance of Microorganisms

Robert M. Clancy1, Carl Langefeld2, Hannah C. Ainsworth3, H. Michael Belmont1, Martin Blaser4, Peter M. Izmirly5, Corey Lacher1, Miranda C Marion6, Mala Masson1, Gregg Silverman7 and Jill P. Buyon1, 1NYU School of Medicine, New York, NY, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 4Director of the NYU Human Microbiome Program, NYU School of Medicine, New York, NY, 5Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 6Biostatistical Sciences and Center for Public Health Genomics, Wake Forest School of Medicine, Winston-Salem, NC, 7Rheumatology, NYU School of Medicine, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: autoantibodies, Biomarkers, classification criteria and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Anti-Ro60 autoantibodies are present in asymptomatic individuals years before onset of disease. We hypothesize that differences in autoreactivity-inducing commensal abundances may drive progression to autoimmune diseases such as SLE. This study tests whether gut pathobionts associate with disease outcome in high titer anti-Ro+ women of children with neonatal lupus.

Methods: The study included 25 healthy controls and 85 anti-Ro+ mothers recruited from the Research Registry for Neonatal Lupus (RRNL); the RRNL consisted of 27 asymptomatic or undifferentiated autoimmune syndrome (UAS) (incomplete) and 58 Sjögren’s Syndrome and/or ACR/SLICC SLE (complete), and 77 SLE patients (non-RRNL, recruited from NYU Specimen and Matched Phenotype Linked Evaluation (SAMPLE)). The rheumatologic diagnoses of the RRNL women were independently determined by two rheumatologists via questionnaire, telephone, and/or in-person history/physical exam, and review of medical records. After extraction of host and non-host genomic DNA from stool, the microbiome was assessed using 16S rRNA gene amplification using standard protocols (mean of 20k sequences per sample). Operational taxonomic units (OTUs) were identified by closed-reference OTU-picking using Green Genes as reference. Shannon’s index (H’) and relative abundance were tested for differences using the Kruskal-Wallis tests. To adjust for multiple comparisons, tests of lower taxa required significance at all higher taxonomic levels, similar to a Fisher’s protected least significant multiple comparisons procedure.

Results: H’ was different for phylum (p=0.0023), class (p<0.0001) and order (p<0.0001), but not family (p=0.62), between controls, RRNL and SLE (non-RRNL). For these three taxonomic levels, the non-RRNL SLE cases had greater diversity than either the controls or RRNL subjects. The strongest differences in relative abundance were for multiple subtaxa of the phylum Firmicutes (p=5.9x10E-4). Within Firmicutes, class Closteridia (p=9.3x10E-6), order Closteridiales (p=9.3x10E-6) show the strongest differences in mean abundance (controls 0.727, RRNL 0.717, SLE (non-RRNL) 0.620). Multiple families within Closteridiales showed significant differences (p<0.01) with Peptostreptococcaceae exhibiting the strongest statistical evidence (mean abundance controls 0.0248, RRNL 0.0303, SLE (non-RRNL) 0.0117; p=3.2E-07). Within RRNL, the complete and incomplete groups had comparable abundances at the order level (complete 0.7156, incomplete 0.7158), suggesting the primary distinction is with non-RRNL SLE cases.

Conclusion: Non-RRNL SLE showed significant increases in fecal diversity and significant reduction in relative abundance at multiple taxa compared to high titer anti-Ro RRNL subjects who in aggregate more closely resemble healthy subjects. Fecal microbiome differences between preclinical and established disease may provide insight regarding anti-Ro positivity and the progression to complete SLE.


Disclosure: R. M. Clancy, None; C. Langefeld, None; H. C. Ainsworth, None; H. M. Belmont, Exagen, 2; M. Blaser, None; P. M. Izmirly, None; C. Lacher, None; M. C. Marion, None; M. Masson, None; G. Silverman, None; J. P. Buyon, Exagen, 2.

To cite this abstract in AMA style:

Clancy RM, Langefeld C, Ainsworth HC, Belmont HM, Blaser M, Izmirly PM, Lacher C, Marion MC, Masson M, Silverman G, Buyon JP. Commensal Gut Bacteria of Anti-Ro Positive Mothers of Children with Neonatal Lupus in Aggregate Resemble Healthy Subjects without Overt Dysbiosis of Abundance of Microorganisms [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/commensal-gut-bacteria-of-anti-ro-positive-mothers-of-children-with-neonatal-lupus-in-aggregate-resemble-healthy-subjects-without-overt-dysbiosis-of-abundance-of-microorganisms/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/commensal-gut-bacteria-of-anti-ro-positive-mothers-of-children-with-neonatal-lupus-in-aggregate-resemble-healthy-subjects-without-overt-dysbiosis-of-abundance-of-microorganisms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology